Immigrant population was selling point in U.S. firm’s choice of city for medical trial
Surrey’s ethnically diverse population has helped make it the perfect testing ground for new device that could potentially screen for infectious and potentially life-threatening diseases in a matter of seconds.
Breathtec Biomedical Inc. (CSE: BTH), a medical diagnostics company based in Florida, announced June 28 that it had hand-picked Surrey to run clinical trials out of Innovation Boulevard.
Continue reading article in Business in Vancouver
Historical Press Releases
This website contains historical and archived press releases for Breathec Biomedical Inc. (“Breathtec”). The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Breathtec and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.